PGIM US Large-Cap Buffer 12 ETF - January PGIM US Large-Cap Buffer 20 ETF - February (BATS: PBFB)

Latest news for PGIM US Large-Cap Buffer 12 ETF - January PGIM US Large-Cap Buffer 20 ETF - February (BATS:PBFB)

The Fund will invest substantially all of its assets in customized equity or index option contracts known as FLexible EXchange Options (FLEX Options) on the SPDR S&P 500 ETF Trust (the Underlying ETF). FLEX Options trade on an exchange, but provide investors with the ability to customize key contract terms like expiration date, option type (put or call), exercise style, strike price, premium, trading hours and exercise settlement, among others

PGIM US Large-Cap Buffer 20 ETF - February

PGIM US Large-Cap Buffer 12 ETF - January PGIM US Large-Cap Buffer 20 ETF - February

WIIM

HUBB

Hubbell shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results.

<p>On Wednesday, <strong>Teva Pharmaceutical Industries Ltd</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) reported second-quarter 2024 sales of $4.16 billion, beating the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus of $4.06 billion</a>.</p>
<p>Revenues increased 7% year-over-year and 11% on constant currency, mainly due to higher revenues from generic products in all segments and Austedo in the U.S. and <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g40063513/teva-announces-strong-growth-in-second-quarter-revenues-mainly-driven-by-generics-products-in-all-" rel="noreferrer noopener">International Markets segments</a>.</p>
<p><strong>Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/24/07/39580399/ftc-crackdown-on-teva-pharmaceuticals-over-inhaler-patent-abuse" rel="noreferrer noopener">FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse</a>.</strong></p>
<p>The company&#8217;s Generics business grew across all regions – it increased in local currency terms by 16% in the U.S., 8% in Europe, and 22% in International Markets, compared to Q2 2023.</p>
<p>Austedo U.S. revenue reached $407 million, an increase of 32% year-over-year. Ajovy&#8217;s global revenues increased by 12% to $115 million.</p>
<p>The company also announced an accelerated development timeline for duvakitug (Anti-TL1A) – top-line results are now expected in Q4 2024, with full data expected next year.</p>
<p>The company reported an adjusted EPS of 61 cents, higher than 56 cents a year ago, beating the consensus of 55 cents.</p>
<p>The adjusted gross profit&nbsp;margin&nbsp;was 52.9% in the second quarter of 2024, compared to 52.2% a year ago, mainly due to a favorable mix of products, primarily driven by growth in Austedo revenues.</p>
<p>Adjusted operating margin reached 25.3%, down from 26.1% a year ago.</p>
<p>Adjusted EBITDA&nbsp;was $1.17 billion in the second quarter of 2024, an increase of 4%, compared to $1,125 million in the second quarter of 2023.</p>
<p><strong>Outlook:</strong> Teva expects fiscal year 2024 revenues of $16.0 billion—$16.4 billion, versus prior guidance of $15.7 billion—$16.3 billion and consensus of $16.012 billion.</p>
<p>The company raised 2024 Austedo sales guidance to $1.6 billion, up from a <a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/b38695507/teva-reports-first-quarter-2024-financial-results-and-reaffirms-2024-financial-outlook" rel="noreferrer noopener">prior outlook of $1.5 billion</a>.</p>
<p>The generic pharma player expects 2024 adjusted EPS of $2.30-$2.50 versus prior guidance of $2.20-$2.50 and consensus of $2.34.</p>
<p><strong>Price Action:</strong> TEVA stock is up 6.22% at $17.43 at last check Wednesday.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/biotech/24/06/39387142/teva-engages-in-settlement-talks-over-medicare-kickback-allegations" target="_blank" rel="noreferrer noopener">Teva Engages In Settlement Talks Over Medicare Kickback Allegations</a>.</strong></li>
</ul>
<p><em>Image created using artificial intelligence via Midjourney.</em></p>


Biotech

Earnings

Large Cap

News

Guidance

Health Care

Movers

Trading Ideas

General

TEVA

Teva Beats Q2 Estimates, Raises Annual Outlook On Strong Generic, Austedo Sales

<p>Truist Securities  analyst Richard Newitter   reiterates Penumbra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEN#NYSE">PEN</a>) with a Buy and lowers the price target from $230 to $200.</p>


Price Target

Reiteration

Analyst Ratings

Truist Securities Reiterates Buy on Penumbra, Lowers Price Target to $200

PDCO

XRAY

In July 2024, Dentsply Sirona Issued A 1-Year Notice To Not Renew Its Distribution Agreements With Patterson Companies, For Dental Equipment In The U.S. And Canada, Planning To Negotiate New Agreements, A Failure To Renegotiate Posing A Potential Material Adverse Effect On Its Business; Co Says Not Expecting A Charge Against Earnings For The Non-Renewal

<p>Truist Securities  analyst Terry Tillman   maintains Paylocity Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCTY#NASDAQ">PCTY</a>) with a Buy and lowers the price target from $200 to $195.</p>


PCTY

Truist Securities Maintains Buy on Paylocity Holding, Lowers Price Target to $195

<p>Truist Securities  analyst Neal Dingmann   maintains ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) with a Hold and raises the price target from $81 to $83.</p>


Truist Securities Maintains Hold on ONEOK, Raises Price Target to $83

<p>Truist Securities  analyst Mark Hughes   maintains NMI Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMIH#NASDAQ">NMIH</a>) with a Buy and raises the price target from $37 to $47.</p>


NMIH

Truist Securities Maintains Buy on NMI Holdings, Raises Price Target to $47

<p>Truist Securities  analyst Michael Ciarmoli   maintains Leonardo DRS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRS#NASDAQ">DRS</a>) with a Buy and raises the price target from $30 to $32.</p>


Truist Securities Maintains Buy on Leonardo DRS, Raises Price Target to $32

<p>Allison Transmission (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALSN#NYSE">ALSN</a>) has outperformed the market over the past 5 years by 1.48% on an annualized basis producing an average annual return of 15.3%. Currently, Allison Transmission has a market capitalization of $7.69 billion. </p>
<p><strong>Buying $1000 In ALSN:</strong> If an investor had bought $1000 of ALSN stock 5 years ago, it would be worth <strong>$2,043.16</strong> today based on a price of $88.22 for ALSN at the time of writing.</p>
<h3>Allison Transmission's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722436393_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ALSN

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today

<p>Truist Securities  analyst Richard Newitter   reiterates Inari Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) with a Hold and lowers the price target from $60 to $55.</p>


NARI

Truist Securities Reiterates Hold on Inari Medical, Lowers Price Target to $55

<p>Jefferies  analyst Omar Nokta   maintains Ardmore Shipping (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASC#NYSE">ASC</a>) with a Buy and raises the price target from $21 to $24.</p>


Jefferies Maintains Buy on Ardmore Shipping, Raises Price Target to $24

<p>Truist Securities  analyst Jamie Cook   maintains Illinois Tool Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITW#NYSE">ITW</a>) with a Buy and lowers the price target from $283 to $281.</p>


Truist Securities Maintains Buy on Illinois Tool Works, Lowers Price Target to $281

<p>Deep-pocketed investors have adopted a bearish approach towards CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CRWD usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 22 extraordinary options activities for CrowdStrike Holdings. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 31% leaning bullish and 54% bearish. Among these notable options, 13 are puts, totaling $2,072,885, and 9 are calls, amounting to $544,206.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $115.0 to $360.0 for CrowdStrike Holdings during the past quarter. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in CrowdStrike Holdings's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to CrowdStrike Holdings's substantial trades, within a strike price spectrum from $115.0 to $360.0 over the preceding 30 days.</p>
<h3>CrowdStrike Holdings Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722436314_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$126.45</td>
<td>$123.25</td>
<td>$124.9</td>
<td>$360.00</td>
<td>$1.5M</td>
<td>230</td>
<td style="text-align: right;">128</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$43.4</td>
<td>$41.95</td>
<td>$42.92</td>
<td>$220.00</td>
<td>$193.1K</td>
<td>897</td>
<td style="text-align: right;">413</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/30/24</td>
<td>$9.0</td>
<td>$8.25</td>
<td>$9.0</td>
<td>$220.00</td>
<td>$90.0K</td>
<td>318</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$67.55</td>
<td>$65.75</td>
<td>$67.55</td>
<td>$300.00</td>
<td>$67.5K</td>
<td>1.8K</td>
<td style="text-align: right;">5</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$18.95</td>
<td>$18.7</td>
<td>$18.95</td>
<td>$270.00</td>
<td>$62.5K</td>
<td>598</td>
<td style="text-align: right;">95</td>
</tr>
</tbody>
</table>
</p>
<h3>About CrowdStrike Holdings</h3>
<p>CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.</p>
<p>Following our analysis of the options activities associated with CrowdStrike Holdings, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of CrowdStrike Holdings</h3>
<ul>
<li>With a volume of 2,869,022, the price of CRWD is up 0.93% at $235.82. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 28 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

CRWD

CrowdStrike Holdings's Options Frenzy: What You Need to Know

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Riot Platforms</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RIOT, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 26 uncommon options trades for Riot Platforms.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 53% bullish and 46%, bearish.</p>
<p>Out of all of the special options we uncovered, 16 are puts, for a total amount of $770,150, and 10 are calls, for a total amount of $518,860.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $20.0 for Riot Platforms over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Riot Platforms's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Riot Platforms's whale activity within a strike price range from $10.0 to $20.0 in the last 30 days. </p>
<h3>Riot Platforms Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722436309_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.01</td>
<td>$2.0</td>
<td>$2.0</td>
<td>$14.00</td>
<td>$122.8K</td>
<td>3.3K</td>
<td>1.1K</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.3</td>
<td>$2.26</td>
<td>$2.26</td>
<td>$10.00</td>
<td>$113.0K</td>
<td>12.1K</td>
<td>3.9K</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.29</td>
<td>$2.28</td>
<td>$2.28</td>
<td>$10.00</td>
<td>$56.7K</td>
<td>12.1K</td>
<td>2.5K</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.0</td>
<td>$1.99</td>
<td>$2.0</td>
<td>$14.00</td>
<td>$56.6K</td>
<td>3.3K</td>
<td>2.0K</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.3</td>
<td>$2.3</td>
<td>$2.3</td>
<td>$10.00</td>
<td>$55.2K</td>
<td>12.1K</td>
<td>845</td>
</tr>
</tbody>
</table>
</p>
<h3>About Riot Platforms</h3>
<p>Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.</p>
<h3>Present Market Standing of Riot Platforms</h3>
<ul>
<li>Trading volume stands at 2,990,362, with RIOT's price up by 2.12%, positioned at $10.59.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 0 days.</li>
</ul>
<h3>Professional Analyst Ratings for Riot Platforms</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $17.75.</p>
<ul>
<li>An analyst from Stifel downgraded its action to Speculative Buy with a price target of $18. </li>
<li>Reflecting concerns, an analyst from HC Wainwright &amp; Co. lowers its rating to Buy with a new price target of $17.</li>
<li>An analyst from Needham persists with their Buy rating on Riot Platforms, maintaining a target price of $13. </li>
<li>An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $23. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Riot Platforms with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


RIOT

Spotlight on Riot Platforms: Analyzing the Surge in Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>JPMorgan Chase</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with JPM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 14 uncommon options trades for JPMorgan Chase.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $153,932, and 11 are calls, for a total amount of $475,959.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $195.0 and $240.0 for JPMorgan Chase, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in JPMorgan Chase's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to JPMorgan Chase's substantial trades, within a strike price spectrum from $195.0 to $240.0 over the preceding 30 days.</p>
<h3>JPMorgan Chase Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1722436304_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$8.2</td>
<td>$8.1</td>
<td>$8.13</td>
<td>$230.00</td>
<td>$81.1K</td>
<td>6.6K</td>
<td>103</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$2.22</td>
<td>$2.21</td>
<td>$2.21</td>
<td>$205.00</td>
<td>$62.3K</td>
<td>4.7K</td>
<td>287</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$12.1</td>
<td>$12.05</td>
<td>$12.05</td>
<td>$220.00</td>
<td>$60.2K</td>
<td>5.1K</td>
<td>55</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$11.8</td>
<td>$11.7</td>
<td>$11.7</td>
<td>$215.00</td>
<td>$58.5K</td>
<td>1.8K</td>
<td>17</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/09/24</td>
<td>$2.93</td>
<td>$2.9</td>
<td>$2.9</td>
<td>$215.00</td>
<td>$58.0K</td>
<td>2.2K</td>
<td>1.6K</td>
</tr>
</tbody>
</table>
</p>
<h3>About JPMorgan Chase</h3>
<p>JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $3.9 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.</p>
<p>Having examined the options trading patterns of JPMorgan Chase, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Current Position of JPMorgan Chase</h3>
<ul>
<li>Currently trading with a volume of 1,639,907, the JPM's price is up by 0.08%, now at $215.37. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 72 days.</li>
</ul>
<h3>Professional Analyst Ratings for JPMorgan Chase</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $217.0.</p>
<ul>
<li>Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on JPMorgan Chase with a target price of $217. </li>
<li>An analyst from Evercore ISI Group persists with their Outperform rating on JPMorgan Chase, maintaining a target price of $210. </li>
<li>Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on JPMorgan Chase with a target price of $211. </li>
<li>An analyst from Oppenheimer persists with their Outperform rating on JPMorgan Chase, maintaining a target price of $221. </li>
<li>Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for JPMorgan Chase, targeting a price of $226. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Market Whales and Their Recent Bets on JPM Options

GRMN

Garmin shares are trading lower. The company reported Q2 financial results.

<p>Truist Securities  analyst Michael Ciarmoli   maintains Howmet Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HWM#NYSE">HWM</a>) with a Buy and raises the price target from $88 to $105.</p>


Truist Securities Maintains Buy on Howmet Aerospace, Raises Price Target to $105

Macro Economic Events

Econ #s

Economics

USA Gasoline Inventories A Draw Of 3.665M	Vs A Draw Of 5.572M Prior

<p>Truist Securities  analyst Michael Roxland   reiterates Graphic Packaging Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) with a Buy and raises the price target from $33 to $35.</p>


The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

PGIM US Large-Cap Buffer 12 ETF - January PGIM US Large-Cap Buffer 20 ETF - February

News

Latest news for PGIM US Large-Cap Buffer 12 ETF - January PGIM US Large-Cap Buffer 20 ETF - February (BATS:PBFB)